Company registration number 10325686 (England and Wales)
SIGMA HEALTH LIMITED
Unaudited financial statements
For the year ended 31 August 2024
SIGMA HEALTH LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 3
SIGMA HEALTH LIMITED
BALANCE SHEET
As at 31 August 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
3
278
Current assets
Cash at bank and in hand
44,433
29,163
Creditors: amounts falling due within one year
4
(24,615)
(21,292)
Net current assets
19,818
7,871
Net assets
20,096
7,871
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
19,996
7,771
Total equity
20,096
7,871
For the financial year ended 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 24 January 2025 and are signed on its behalf by:
Dr A Basu
Director
Company registration number 10325686 (England and Wales)
SIGMA HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS
For the year ended 31 August 2024
- 2 -
1
Accounting policies
Company information
Sigma Health Limited is a private company limited by shares incorporated in England and Wales. The registered office is .
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
These financial statements for the year ended 31 August 2024 are the first financial statements of Sigma Health Limited prepared in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland. The date of transition to FRS 102 was 1 September 2022. The reported financial position and financial performance for the previous period are not affected by the transition to FRS 102.
1.2
Turnover
Turnover represents the consideration received or receivable for professional services provided.
1.3
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Fixtures and fittings
10% per annum
Computers
33% per annum
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.4
Taxation
The tax expense represents the tax currently payable.
Current tax
The tax currently payable is based on taxable profit for the year. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
SIGMA HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (continued)
For the year ended 31 August 2024
- 3 -
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2024
2023
Number
Number
Total
3
Tangible fixed assets
Computer equipment
£
Cost
At 1 September 2023
1,466
Additions
400
At 31 August 2024
1,866
Depreciation
At 1 September 2023
1,466
Depreciation charged in the year
122
At 31 August 2024
1,588
Net Book Value
At 31 August 2024
278
At 31 August 2023
4
Creditors: amounts falling due within one year
2024
2023
£
£
Corporation tax
2,774
1,293
Other creditors
21,841
19,999
24,615
21,292